Equity Research, Broker Reports, and media content on Abivax SA

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Abivax SA
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Abivax SA

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Abivax SA. We currently have 17 research reports from 2 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 540/2540c
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: 83.0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
25Jun19 15:16 EQS Abivax SA (ABVX-FR): Ready to deal with inflammation
11Mar19 14:54 EQS Abivax SA (ABVX-FR): ABX464: sustained safety and benefit in inflammatory bowel
22Jan19 14:58 EQS Abivax SA (ABVX-FR): Getting a brake in inflammation
06Sep18 10:16 EQS Abivax SA (ABVX-FR): Remarkable data opens door to $15bn IBD market
04Jul18 11:34 EQS Abivax SA (ABVX-FR): ABX464 reduces HIV DNA in latent viral gut reservoir
  • Frequency of research reports

     

  • Research reports on

    Abivax SA

  • Providers covering

    Abivax SA